Javier
Arbizu Lostao
Consultor Médico
Forschungszentrum Jülich
Jülich, AlemaniaPublicacions en col·laboració amb investigadors/es de Forschungszentrum Jülich (7)
2021
-
Finding our way through the labyrinth of dementia biomarkers
European Journal of Nuclear Medicine and Molecular Imaging
2020
-
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962
-
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912
-
Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant
European Journal of Nuclear Medicine and Molecular Imaging
2019
-
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [ 18 F]FDG: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, Núm. 3, pp. 540-557
2017
-
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
NeuroImage: Clinical, Vol. 13, pp. 386-394
2016
-
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Neuro-Oncology, Vol. 18, Núm. 9, pp. 1199-1208